Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

34.41
+0.19500.57%
Post-market: 34.20-0.2100-0.61%17:50 EDT
Volume:890.95K
Turnover:30.56M
Market Cap:21.16B
PE:27.20
High:34.66
Open:34.63
Low:34.08
Close:34.22
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:0.51
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.55
PE(LYR):22.39

Loading ...

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jun 18

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Dianthus Therapeutics (DNTH) and Aurora Cannabis (ACB)

TIPRANKS
·
Jun 15

Genmab announces new data from studies evaluating epcoritamab

TIPRANKS
·
Jun 15

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 12

Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook

TIPRANKS
·
Jun 12

Genmab Says Subgroup Data for Follicular Lymphoma Treatment Shows 'Sustained' Efficacy Benefits

MT Newswires Live
·
Jun 11

Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress

TIPRANKS
·
Jun 11

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 11

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 09

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 04

Wells Fargo Gives a Buy Rating to Genmab (GMAB)

TIPRANKS
·
Jun 02

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

Genmab A/S Stock Falls Thursday, Underperforms Market

Dow Jones
·
May 29

Genmab assumed with a Buy at Truist

TIPRANKS
·
May 27

Genmab (GMAB) Has a New Rating from Truist Financial

TIPRANKS
·
May 27

Genmab : Truist Securities Assumes Coverage With Buy Rating; Target Price $40 VS $48

THOMSON REUTERS
·
May 27

Genmab A/S Stock Rises Tuesday, Outperforms Market

Dow Jones
·
May 27

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)

TIPRANKS
·
May 26